These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12614230)

  • 1. Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura.
    Culić S
    Br J Haematol; 2003 Mar; 120(5):909-10. PubMed ID: 12614230
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant factor VIIa in a thrombocytopenic patient with spontaneous intracerebral haemorrhage.
    Busani S; Marietta M; Pasetto A; Girardis M
    Thromb Haemost; 2005 Feb; 93(2):381-2. PubMed ID: 15711759
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboelastography-guided recombinant factor VIIa administration in a patient with refractory autoimmune idiopathic thrombocytopenia.
    James KM; Melikian CN; Chowdary P; Mallett SV
    Anesth Analg; 2008 Aug; 107(2):402-5. PubMed ID: 18633015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII: panacea or passing fad?
    Parker RI
    Pediatr Crit Care Med; 2005 May; 6(3):379-80. PubMed ID: 15880015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of recombinant activated factor VII (NovoSeven) in the treatment of a patient with idiopathic thrombocytopenic purpura complicated with subarachnoid and parenchimatous hemorrhage].
    Vyhovs'ka IaI; Karol' IuS; Fedak LM; Tsytsyk OI
    Lik Sprava; 2004; (7):77-81. PubMed ID: 15724622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Factor VIIa in blunt pelvic trauma.
    Hurst T; Blanckley S; Forrest M
    Anaesthesia; 2005 Dec; 60(12):1244-5; author reply 1245. PubMed ID: 16288629
    [No Abstract]   [Full Text] [Related]  

  • 7. Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura.
    Baxter MS; Schroeder WS; Cheng Y; Bernstein ZP
    Ann Pharmacother; 2006 Nov; 40(11):2053-8. PubMed ID: 17062831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
    Despotis G; Avidan M; Lublin DM
    Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
    [No Abstract]   [Full Text] [Related]  

  • 9. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
    Tanchev S; Platikanov V; Karadimov D
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
    [No Abstract]   [Full Text] [Related]  

  • 10. Preemptive use of recombinant activated factor VII: many questions but few answers.
    Samama CM
    Can J Anaesth; 2006 Apr; 53(4):336-8. PubMed ID: 16575029
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful use of activated recombinant factor VII in traumatic liver injuries in children.
    Kulkarni R; Daneshmand A; Guertin S; Fath J; Atwal M; Melvin J; LaFrance S
    J Trauma; 2004 Jun; 56(6):1348-52. PubMed ID: 15211149
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
    Aguilar C; Lucía JF
    Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
    Yan Q; Chang AC
    Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
    Veneri D; Franchini M
    Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
    Udy A; Vaghela M; Lawton G; Sigston P
    Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia.
    Tuffigo M; Lazaro E; James C; Subtil C; Viallard JF; Fiore M
    Haemophilia; 2015 Jan; 21(1):e116-8. PubMed ID: 25471665
    [No Abstract]   [Full Text] [Related]  

  • 18. The potential use of recombinant activated factor VII in trauma and surgery.
    Sapsford W
    Scand J Surg; 2004; 93(1):17-23. PubMed ID: 15116814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue.
    Larsen OH; Clausen N; Persson E; Ezban M; Ingerslev J; Sørensen B
    Br J Haematol; 2009 Jan; 144(1):99-106. PubMed ID: 19016728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.